The global closed system transfer devices market size attained a value of USD 879.3 million in 2022. The rapid Growth in Hospitals and Clinics is the main reason to Fuel the Market Growth of Closed System Transfer Devices. The market is anticipated to grow at a CAGR of 19.2% during the forecast period of 2023-2031 to attain a value of USD 4,306 million by 2031.
During the forecast period, the region of North America is expected to account for a significant market share on account of the high awareness regarding such devices among nurses, pharmacists, and oncologists. Cancer is highly prevalent in the region, and there is a strong presence of various market players such as Baxter International Inc. and Becton, Dickinson, and Company, among others. Both these factors, as well as easy accessibility to advanced technologies, are expected to propel the growth of the closed system transfer devices market in North America.
Meanwhile, Asia Pacific is projected to bolster the market growth of closed system transfer devices during the forecast period on account of the surging utilisation in Asia Pacific. There is a rising demand for advanced healthcare services, an increase in the overall population, and increasing investments of international players in emerging economies like India and China.
A Closed System Drug-Transfer Device (CSTD) is primarily classified as a drug transfer device, used to mechanically excludes the transfer of environmental toxins into the system. They also evade harmful drug or vapor concentrations that maybe located outside the system. They usually feature one of two design concepts, utilising a physical barrier for transfer exclusion, or an air-cleaning technology to prevent escape of harmful drugs into the surrounding environments.
By type, the bifurcation of the market is into:
Based on technology, the market is categorised into:
On the basis of end uses, the closed system transfer devices market is segregated into:
The EMR report looks into the regional markets of closed system transfer devices like Latin America, North America, Europe, the Asia Pacific, and the Middle East and Africa.
Based on end use, the segment expected to register robust growth market across the globe is hospitals and clinics. Hospitals have strong financial capabilities for acquiring high-priced devices, a large cancer patient population, and a requirement to obey with regulatory guidelines, bolstering market demand from hospitals.
Advancements in medical research and technology and the growing healthcare industry are expected to fuel the closed system transfer devices market growth globally. There is a surging usage of the needleless segment as it offers a faster and more efficient way of administering vaccines coupled. Strict medical guidelines for safe usage of harmful drugs is also likely to drive the market growth.
The report presents a detailed analysis of the following key players in the global closed system transfer devices market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the market. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Type||
|Breakup by Technology||
|Breakup by Component||
|Breakup by End User||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Closed System Transfer Devices Market Overview
3.1 Global Closed System Transfer Devices Market Historical Value (2016-2022)
3.2 Global Closed System Transfer Devices Market Forecast Value (2023-2031)
4 Global Closed System Transfer Devices Market Landscape
4.1 Global Closed System Transfer Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Closed System Transfer Devices Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Component
4.2.4 Analysis by End User
5 Global Closed System Transfer Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Closed System Transfer Devices Market Segmentation
6.1 Global Closed System Transfer Devices Market by Type
6.1.1 Market Overview
6.1.3 Membrane to Membrane
6.2 Global Closed System Transfer Devices Market by Technology
6.2.1 Market Overview
6.2.2 Diaphragm Based
6.3 Global Closed System Transfer Devices Market by Component
6.3.1 Market Overview
6.4 Global Closed System Transfer Devices Market by End User
6.4.1 Market Overview
6.4.2 Hospitals and Clinics
6.4.3 Academic and Research Institute
6.5 Global Closed System Transfer Devices Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Closed System Transfer Devices Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Closed System Transfer Devices Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Closed System Transfer Devices Market
9.1 Market Share by Country
10 Latin America Closed System Transfer Devices Market
10.1 Market Share by Country
11 Middle East and Africa Closed System Transfer Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 Baxter International Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 B. Braun Holding Gmbh & Co. Kg
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Becton, Dickinson, and Company
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 Corvida Medical, Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 Caragen Ltd
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 ICU Medical
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 YUKON MEDICAL
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 JMS North America Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11 Epic Medical
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
18 Global Closed System Transfer Devices Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
Globally, closed system transfer devices market reached a value of USD 879.3 million in 2022.
The market is projected to expand at a CAGR of 19.2% from 2022 to 2031, growing to USD 4306 million by 2031.
The leading market drivers are surging the healthcare industry and the increasing prevalence of chronic disease.
The key market trends include the surging use of closed system transfer devices to combat harmful effects of cytotoxic and antineoplastic drugs, and growing investment in healthcare infrastructure.
The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. Currently, the EMR report identifies North America as holding a significant market share.
The various types of devices in the market includes needleless and membrane to membrane.
The core technologies in the market includes diaphragm based, filtration, and compartmentalised.
The most common end user segments in the market include hospitals and clinics and oncology centres.
The major players in the market are Baxter International Inc., B. Braun Holding Gmbh & Co. Kg, Becton, Dickinson, and Company, Corvida Medical, Inc. and Caragen Ltd, among others.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.